TY  - GEN
AU  - Pietri,Elisabetta
AU  - Massa,Ilaria
AU  - Bravaccini,Sara
AU  - Ravaioli,Sara
AU  - Tumedei,Maria Maddalena
AU  - Petracci,Elisabetta
AU  - Donati,Caterina
AU  - Schirone,Alessio
AU  - Piacentini,Federico
AU  - Gianni,Lorenzo
AU  - Nicolini,Mario
AU  - Campadelli,Enrico
AU  - Gennari,Alessandra
AU  - Saba,Alessandro
AU  - Campi,Beatrice
AU  - Valmorri,Linda
AU  - Andreis,Daniele
AU  - Fabbri,Francesco
AU  - Amadori,Dino
AU  - Rocca,Andrea
TI  - Phase II Study of Dehydroepiandrosterone in Androgen Receptor-Positive Metastatic Breast Cancer
SN  - 1549-490X
PY  - 2020///0720
KW  - Administration, Oral
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - administration & dosage
KW  - Aromatase Inhibitors
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Dehydroepiandrosterone
KW  - Disease Progression
KW  - Drug-Related Side Effects and Adverse Reactions
KW  - epidemiology
KW  - Female
KW  - Humans
KW  - Middle Aged
KW  - Prospective Studies
KW  - Receptors, Androgen
KW  - metabolism
KW  - Receptors, Estrogen
KW  - Response Evaluation Criteria in Solid Tumors
KW  - Survival Analysis
KW  - Time Factors
KW  - Triple Negative Breast Neoplasms
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1634/theoncologist.2018-0243
ER  -